Medlab Clinical (ASX:MDC) Days Sales Outstanding : 330.78 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Medlab Clinical Days Sales Outstanding?

Medlab Clinical's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.09 Mil. Medlab Clinical's Revenue for the six months ended in Dec. 2023 was A$0.05 Mil. Hence, Medlab Clinical's Days Sales Outstanding for the six months ended in Dec. 2023 was 330.78.

The historical rank and industry rank for Medlab Clinical's Days Sales Outstanding or its related term are showing as below:

ASX:MDC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.28 Med: 84.03 Max: 803.28
Current: 803.28

During the past 8 years, Medlab Clinical's highest Days Sales Outstanding was 803.28. The lowest was 39.28. And the median was 84.03.

ASX:MDC's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.67 vs ASX:MDC: 803.28

Medlab Clinical's Days Sales Outstanding declined from Dec. 2022 (331.58) to Dec. 2023 (330.78).

Medlab Clinical Days Sales Outstanding Historical Data

The historical data trend for Medlab Clinical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Days Sales Outstanding Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

87.89

168.72

104.88

257.38

39.28

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial												784.96	227.26	331.58	678.79	330.78

Competitive Comparison of Medlab Clinical's Days Sales Outstanding

For the Biotechnology subindustry, Medlab Clinical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's Days Sales Outstanding falls into.

Medlab Clinical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medlab Clinical's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.089	+	0.103)	/	2 )	/	0.892	*	365
=	0.096					/	0.892	*	365
=	39.28

Medlab Clinical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.103	+	0.071)	/	2 )	/	0.048	*	365 / 2
=	0.087					/	0.048	*	365 / 2
=	330.78

Medlab Clinical (ASX:MDC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medlab Clinical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (ASX:MDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (ASX:MDC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.